GIA
TECH icon

Gateway Investment Advisers’s Bio-Techne TECH Stock Holding History

Gateway Investment Advisers’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$272K Sell
3,847
-5,865
-60% -$317K ﹤0.01% 726
2026
Q1 		$508K Buy
+9,712
New +$583K 0.01% 485
2022
Q1 		– Sell
-2,656
Closed -$344K – 566
2021
Q4 		$344K Sell
2,656
-268
-9% -$32.9K ﹤0.01% 459
2021
Q3 		$354K Buy
2,924
+736
+34% +$89.6K ﹤0.01% 455
2021
Q2 		$246K Sell
2,188
-260
-11% -$27.4K ﹤0.01% 510
2021
Q1 		$234K Sell
2,448
-392
-14% -$35.8K ﹤0.01% 510
2020
Q4 		$225K Buy
+2,840
New +$206K ﹤0.01% 509

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Gateway Investment Advisers's TECH Position: Q2 2026 in Review

Gateway Investment Advisers reduced its Bio-Techne (TECH) stake by 60% in Q2 2026, selling an estimated $317K and leaving 3,847 shares worth $272K. The position accounts for ﹤0.01% of the portfolio, ranked #726.

Gateway Investment Advisers first reported a position in TECH in Q4 2020 and has held it in 7 quarters since. The position peaked at $508K in Q1 2026. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Gateway Investment Advisers held 3,847 shares of Bio-Techne worth $272K as of Q2 2026.
  • Gateway Investment Advisers sold 5,865 Bio-Techne shares in Q2 2026, an estimated $317K.
  • Bio-Techne made up ﹤0.01% of Gateway Investment Advisers's portfolio in Q2 2026, its #726 holding.
  • Gateway Investment Advisers first reported a position in Bio-Techne in Q4 2020 and has held it in 7 quarters since.
  • Gateway Investment Advisers's Bio-Techne position peaked at $508K in Q1 2026.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Gateway Investment Advisers's 13F filing for Q2 2026, filed 20 Jul 2026.